Literature DB >> 20541681

Do hormones influence melanoma? Facts and controversies.

Amie Gupta1, Marcia S Driscoll.   

Abstract

The issue of whether hormones influence malignant melanoma (MM) has been controversial for many years. Although early case reports demonstrated a negative effect of hormones, recent evidence has not supported a potential role for hormones in MM. We address whether exogenous and endogenous hormones influence a woman's risk for MM or affect her prognosis if diagnosed with MM. Multiple epidemiologic studies show the use of oral contraceptives or hormone replacement therapy does not appear to increase a woman's risk for MM. Pregnancy does not appear to influence a woman's risk of MM, nor does pregnancy appear to affect prognosis in the woman diagnosed with MM. When counseling the woman who is diagnosed with MM during pregnancy or during the childbearing years, future use of oral contraceptives or hormone replacement therapy is not contraindicated; counseling concerning future pregnancies should be done on a case-by-case basis, with emphasis placed on established prognostic factors for MM. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541681     DOI: 10.1016/j.clindermatol.2010.04.003

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  15 in total

Review 1.  [Melanoma and pregnancy].

Authors:  C Erfurt-Berge; E Kaempgen
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

2.  Age at first birth and melanoma risk: a meta-analysis.

Authors:  Zhengyong Li; Mingjin Gu; Ying Cen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology.

Authors:  Lisa R Kallenbach; Kirby L Johnson; Diana W Bianchi
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

4.  Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.

Authors:  Jean Y Tang; Katrina M Spaunhurst; Rowan T Chlebowski; Jean Wactawski-Wende; Elizabeth Keiser; Fridtjof Thomas; Matthew L Anderson; Nathalie C Zeitouni; Joseph C Larson; Marcia L Stefanick
Journal:  J Natl Cancer Inst       Date:  2011-08-30       Impact factor: 13.506

5.  Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes?

Authors:  Maris S Jones; Jihey Lee; Stacey L Stern; Mark B Faries
Journal:  J Am Coll Surg       Date:  2017-04-27       Impact factor: 6.113

6.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

7.  Melanoma developed during pregnancy--a case report.

Authors:  Natalia Cammarosano Mestnik; João Paulo Junqueira Magalhães Afonso; Milvia Maria Simões e Silva Enokihara; Mauro Yoshiaki Enokihara; Adriana Maria Porro; Sérgio Henrique Hirata
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

8.  Cutaneous Melanoma in Women.

Authors:  Mi Ryung Roh; Philip Eliades; Sameer Gupta; Hensin Tsao
Journal:  Int J Womens Dermatol       Date:  2015-02-01

9.  Influence of gender and age on the survival of patients with nasopharyngeal carcinoma.

Authors:  Guangli Xiao; Yabing Cao; Xibin Qiu; Weihua Wang; Yufeng Wang
Journal:  BMC Cancer       Date:  2013-05-04       Impact factor: 4.430

10.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.